A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer
Objectives: Few studies have assessed the effect of gonadotropin-releasing hormone (GnRH) agonists, such as triptorelin, on lower urinary tract symptoms (LUTS) in patients with advanced prostate cancer. Therefore, multiple, national observational, noninterventional studies were initiated to assess t...
Main Authors: | Thierry Gil, Fouad Aoun, Patrick Cabri, Pascal Maisonobe, Roland van Velthoven |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-06-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287215574480 |
Similar Items
-
Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study
by: Thierry Gil, et al.
Published: (2017-07-01) -
Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study
by: Alexandre Peltier, et al.
Published: (2015-01-01) -
Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients
by: Woo HH, et al.
Published: (2017-02-01) -
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study
by: Le-Ye He, et al.
Published: (2018-03-01) -
Lower Urinary Tract Dysfunction in Pelvic Gynecologic Cancer: The Role of Urodynamics
by: Fouad Aoun, et al.
Published: (2014-01-01)